Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
175 Leser
Artikel bewerten:
(1)

INFORMA MARKETS - ENGINEERING: Avrio Institute, LeaderLogic to Keynote 40th Edition of MD&M West

Finanznachrichten News

Registration for the leading B2B event in the medical device and advanced manufacturing industry is now open.

ANAHEIM, CA / ACCESSWIRE / November 4, 2024 / MD&M West, the most comprehensive manufacturing trade show in North America (February 4-6, 2025 at the Anaheim Convention Center in Anaheim, California), announces Dr. Shawn DuBravac, Chief Executive Officer and President, Avrio Institute, and Nick Webb, Chief Executive Officer, LeaderLogic, as keynote speakers for the 2025 event.

Amid rapid changes across the advanced manufacturing landscape, Webb's keynote, "Driving Growth and Innovation in Medical Device Design, Manufacturing, and Packaging," will provide actionable insights and powerful takeaways. This session equips attendees with the tools necessary to drive growth, foster innovation, and implement cutting-edge technologies to successfully navigate the evolving landscape of 2025 and beyond. Drawing on his experience with multibillion-dollar clients through LeaderLogic, Webb will share practical strategies that empower leaders to anticipate industry shifts and seize emerging opportunities.

Dr. Shawn DuBravac, the New York Times best-selling author with a focus on mass adoption of new technologies, will explore how AI is transforming manufacturing by driving efficiency, enhancing product quality, and enabling customization and sustainability. In "AI and the Future of Manufacturing: Envisioning What's Next," Dr.DuBravac will highlight real-world case studies showcasing successful AI implementations in manufacturing, emphasizing the tangible benefits and lessons learned from these initiatives.

"MD&M West celebrates 40 years with a new overarching brand name and the continued emphasis on collaboration, adaptability and future focused strategies that drive manufacturing success," says Melissa Magestro, VP, Informa Markets Engineering. "With advancements in AI, design, evolving care delivery models and sustainability reshaping the industry, MD&M West unites leaders across manufacturing, medical devices and plastics sectors for meaningful conversations and exchange."

California is the epicenter for manufacturing output in the United States with over 35,000 manufacturing firms employing over 1 million Californians. On a global scale, the manufacturing market is projected to grow 1.15% annually from 2024 to 2029, reaching a market volume of $9.3 trillion by 2029. In terms of value added, the US ranks second in manufacturing market in the world, making MD&M a vital platform for industry leaders to collaborate and drive the sector forward.

The show will also feature over 40 conference sessions, 5 workshops and 30 plus free educational sessions on the show floor.

Registration for MD&M West is now open. The expo pass also provides access to Sustainable Manufacturing Expo, a new event dedicated to showcasing the latest technologies, innovations and thought leadership for progressing sustainable manufacturing processes forward, taking place February 4-5, 2025 in the North Hall.

About MD&M
MD&M, organized by Informa Markets Engineering, is the leading group of business events across the U.S. for professionals in medical, critical and advanced manufacturing. United under one brand, MD&M is the premier platform where professionals meet, learn and collaborate to drive innovations in life-saving devices, cutting-edge technologies and advanced manufacturing processes. Founded in 1985, the MD&M portfolio includes MD&M West, MD&M East, MD&M South and MD&M Midwest. Focusing on fostering collaboration across regions and sectors, MD&M is dedicated to empowering professionals through year-round engagement, advanced matchmaking technology and specialized events that reflect the ever-evolving needs of the industry.

About Informa Markets Engineering
Informa Markets Engineering, a subsidiary of Informa plc (LON:INF), is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibition organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.

Media Contact
Informa Markets Engineering PR
EngineeringPR@informa.com

SOURCE: INFORMA MARKETS - ENGINEERING



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.